TITLE

Bronchoalveolar lavage in talc induced lung disease

AUTHOR(S)
De Vuyst, P; Dumortier, P; Leophonte, P
PUB. DATE
July 1989
SOURCE
Thorax;Jul1989, Vol. 44 Issue 7, p607
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
66123907

 

Related Articles

  • Bronchoalveolar Lavage: Role in the Pathogenesis, Diagnosis, and Management of Interstitial Lung Disease. Daniele, Ronald P.; Elias, Jack A.; Epstein, Paul E.; Rossman, Milton D. // Annals of Internal Medicine;Jan85, Vol. 102 Issue 1, p93 

    Discusses the status of bronchoalveolar lavage as an investigative tool and assesses its advantages and limitations in the clinical setting. Assessment of interstitial lung diseases by lavage; Information on the lavage procedure; Constituents of normal airways.

  • Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Bjermer, Leif; Engstrom-Laurent, Anna; Lundgren, Rune; Rosenhall, Leif; Hallgren, Roger // British Medical Journal (Clinical Research Edition);10/3/1987, Vol. 295 Issue 6602, p803 

    Investigates the hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity of farmer's lung. Prominence of impaired diffusion capacity; Decline of lavage fluid concentrations; Increase in risk of fibrotic lung disease.

  • Bronchoalveolar Lavarge in Interstitial Lung Disease. Weinberger, Steven E.; Kelman, Jeffrey A.; Elson, Norton A.; Young Jr., Roscoe C.; Reynolds, Herbert Y.; Fulmer, Jack D.; Crystal, Ronald G. // Annals of Internal Medicine;Oct78, Vol. 89 Issue 4, p459 

    Investigates the cellular and immunoglobulin components of bronchoalveolar fluid recovered by bronchoscopic lavage in control patients, volunteers and patients with interstitial lung diseases. Materials and methods; Prospective analysis of effects of corticosteroid treatment on lavage fluid...

  • Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies. Costabel, U.; Bross, K.J.; Matthys, H. // British Medical Journal (Clinical Research Edition);4/6/1985, Vol. 290 Issue 6474, p1041 

    Examines the cause of pulmonary infiltrates in haematological malignancies through bronchoalveolar lavage diagnosis in Great Britain. Examination of interstitial lung disease in patients with malignant lymphoma; Occurrence of bleeding in coagulopathy; Analysis of the recovered cells for surface...

  • Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide. Moon, Andres; Gil, Sucheol; Gill, Sean E.; Chen, Peter; Matute-Bello, Gustavo // Journal of Inflammation;2012, Vol. 9 Issue 1, p31 

    Background: Tetracyclines are broad-spectrum antibiotics that are also used to induce gene expression using the reverse tetracycline transactivator / tetracycline operator system (rtTA/tetO system). The system assumes that tetracyclines have no effects on mammals. However, a number of studies...

  • The many uses of bronchoalveolar lavage. Morrison, Heather M.; Stockley, Robert A. // British Medical Journal (Clinical Research Edition);6/25/1988, Vol. 296 Issue 6639, p1758 

    Evaluates the uses of bronchoalveolar lavage in Great Britain. Definition of bronchoalveolar lavage; Importance of the technique in treating cystic fibrosis; Effectiveness of the technique for the treatment of alveolar proteinosis; Utilization of the technique in diagnosing opportunistic...

  • Aerosolized bovine lactoferrin reduces lung injury and fibrosis in mice exposed to hyperoxia. Chen, Hsiao-Ling; Yen, Chih-Ching; Wang, Shih-Ming; Tsai, Tung-Chou; Lai, Zi-Lun; Sun, Jheng-Yue; Lin, Willei; Hsu, Wu-Huei; Chen, Chuan-Mu // BioMetals;Oct2014, Vol. 27 Issue 5, p1057 

    This study investigated the ability of aerosolized bovine lactoferrin (bLF) to protect the lungs from injury induced by chronic hyperoxia. Female CD-1 mice were exposed to hyperoxia (FiO = 80 %) for 7 days to induce lung injury and fibrosis. The therapeutic effects of bLF, administered via an...

  • Successful Crizotinib Rechallenge After Crizotinib-induced Interstitial Lung Disease. Tachihara, Motoko; Kobayashi, Kazuyuki; Ishikawa, Yumiko; Hori, Suya; Tamura, Daisuke; Otera, Hiroshi; Funada, Yasuhiro; Nishimura, Yoshihiro // Japanese Journal of Clinical Oncology;Aug2014, Vol. 44 Issue 8, p762 

    We report the case of a 70-year-old Japanese male diagnosed with advanced lung adenocarcinoma harboring the echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene. As soon as crizotinib was administered, tumor shrank immediately. On Day 25, he developed...

  • Cytokine production by brochoalveolar lavage cells in chronic beryllium disease. Tinkle, Sally S.; Schwitters, Patricia W. // Environmental Health Perspectives Supplements;Oct96 Supplement 5, Vol. 104, p969 

    Analyzes cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Sensitizing cell-mediated immune response to beryllium antigen that progresses to granulomatous lung disease; Involvement of proinflammatory cytokines in the disease process; T-lymphocyte proliferation by...

  • Interstitial Lung Disease in Children. D., VIJAYASEKARAN // Indian Pediatrics;Jan2013, Vol. 50 Issue 1, p59 

    The article talks about a study that classified patients with interstitial lung disease (ILD) as definite and possible subgroups. The study's contribution to ILD disease unique to infancy is highlighted. The usefulness of bronchoalveolar lavage and high resolution computed tomography is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics